Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate he has made of the cost to the public purse of the Success Regime in North, East and West Devon.
Answered by Philip Dunne
The Success Regime was launched in June 2015 and is aimed at providing challenge and support to some of the most challenged health and care economies in the country in order to improve the quality and sustainability of services offered to local people. It takes a whole systems-approach to help address long-standing, deep-rooted and systemic issues. The programme will oversee progress from diagnosis of the underlying issues through to implementation of solutions, and aims to build local leadership capacity in order to ensure that improvements made are maintained.
The allocations followed a business case process and were approved by NHS England. The information requested is shown in the following table:
Allocations to the Success Regimes in 2015/16 and 2016/17
Success Regime | 2015/16 | 2016/17 |
Devon Success Regime | £1.4 million | £6.0 million |
Mid and South Essex Success Regime | £900,000 | £5.7 million |
West, North and East Cumbria Success Regime | £1.2 million | £5.0 million |
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate he has made of the cost to the public purse of the Success Regime in Mid and South Essex.
Answered by Philip Dunne
The Success Regime was launched in June 2015 and is aimed at providing challenge and support to some of the most challenged health and care economies in the country in order to improve the quality and sustainability of services offered to local people. It takes a whole systems-approach to help address long-standing, deep-rooted and systemic issues. The programme will oversee progress from diagnosis of the underlying issues through to implementation of solutions, and aims to build local leadership capacity in order to ensure that improvements made are maintained.
The allocations followed a business case process and were approved by NHS England. The information requested is shown in the following table:
Allocations to the Success Regimes in 2015/16 and 2016/17
Success Regime | 2015/16 | 2016/17 |
Devon Success Regime | £1.4 million | £6.0 million |
Mid and South Essex Success Regime | £900,000 | £5.7 million |
West, North and East Cumbria Success Regime | £1.2 million | £5.0 million |
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the oral contribution of the Parliamentary Under-Secretary of State for Health of 14 September 2016, Official Report, column 998, if he will deposit a document in the Library describing how stakeholders will be consulted as part of the NHS Sustainability and Transformation Plans.
Answered by David Mowat
Guidance on consultation as part of the National Health Service Sustainability and Transformation Plans, entitled ‘Engaging local people’ was published on the 15 September 2016. A copy has been placed in the Library and is also available at the following address:
https://www.england.nhs.uk/wp-content/uploads/2016/09/engag-local-people-stps.pdf
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, with reference to the Written Ministerial Statement of 6 December 2010, Col 7WS, what consideration his Department has given to the articles of the UN Convention on the Rights of the Child when making new policy and legislation since May 2015.
Answered by Baroness Blackwood of North Oxford
The Department recognises the importance of considering the articles of the United Nations Convention on the Rights of the Child when making new policy and legislation.
Alongside other Government Departments we report every five years to the UN Committee on our compliance. Following the most recent oral hearing in May 2016, the UN Committee has made a number of concluding observations. We will be able to demonstrate progress against these observations during the next reporting round.
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will make an assessment of the contribution of free delivery services for medicines from community pharmacies to the number of prescriptions which are successfully received.
Answered by Alistair Burt
We have made no assessment. Information on the range of services individual community pharmacies choose to provide free to their customers beyond those commissioned by the National Health Service is not collected.
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, which areas will be eligible for the proposed Pharmacy Access Scheme.
Answered by Alistair Burt
We intend to announce details of the Pharmacy Access Scheme, including which pharmacies will be eligible in due course, as part of a wider announcement on community pharmacy in 2016/17 and beyond.
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what resources his Department has allocated to assessing the counter-proposal to the Government's plans for community pharmacy published by the Pharmaceutical Services Negotiating Committee in April 2016.
Answered by Alistair Burt
We have been developing our proposals for community pharmacy in 2016/17 and beyond in discussion with the Pharmaceutical Services Negotiating Committee (PSNC) and other stakeholders. We welcomed the publication of the PSNC’s counter proposal which is being considered as part of the consultation process. Our aim is to communicate our final decisions early in July.
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, whether his Department plans to respond to the counter-proposal to the Government's plans for community pharmacy published by the Pharmaceutical Services Negotiating Committee in April 2016.
Answered by Alistair Burt
We have been developing our proposals for community pharmacy in 2016/17 and beyond in discussion with the Pharmaceutical Services Negotiating Committee (PSNC) and other stakeholders. We welcomed the publication of the PSNC’s counter proposal which is being considered as part of the consultation process. Our aim is to communicate our final decisions early in July.
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the rate of dementia among each (a) age group and (b) gender in (i) Allerdale borough and (ii) Copeland borough has been in each of the last 10 years.
Answered by Jane Ellison
Information is not available in the format requested.
The number of people recorded on the practice dementia disease register is available in the Quality and Outcomes Framework (QOF), published by the Health and Social Care Information Centre, from 2006/07, when dementia indicators were introduced into the framework. The diagnosis rate is not available but the numbers of people on the dementia register are available. This is a measure of prevalence rather than incidence.
Number of patients on the QOF Dementia Register in Cumbria as at 31 March
Area | Year | Number of GP practices | Number of patients on the Dementia Register | Prevalence (%) |
NHS Cumbria Clinical Commissioning Group (CCG) | 2013-14 | 82 | 4,602 | 0.88 |
NHS Cumbria CCG | 2012-13 | 82 | 4,248 | 0.81 |
Cumbria Teaching Primary Care Trust (PCT) | 2011-12 | 83 | 3,938 | 0.76 |
Cumbria PCT | 2010-11 | 90 | 3,524 | 0.68 |
Cumbria PCT | 2009-10 | 91 | 3,318 | 0.64 |
Cumbria PCT | 2008-09 | 92 | 3,114 | 0.60 |
Cumbria PCT | 2007-08 | 93 | 3,008 | 0.58 |
Cumbria PCT | 2006-07 | 95 | 2,856 | 0.56 |
Source: Health and Social Care Information Centre
Notes:
1. Data is received at practice level, however the practice data cannot be used to estimate prevalence for small areas as practices serve registered patients, not defined geographical areas. The QOF data has been provided down to CCG/PCT level.
2. The figures provided are a snapshot ‘as at 31 March each year’ and are for people of all ages, as a breakdown by age group and gender is not available.
3. The objective of the QOF is to improve the quality of care that patients are given by rewarding practices for the quality of care they provide to their patients. QOF is therefore an incentive payment scheme. Participation by practices is entirely voluntary, though participation rates are over 95%.
4. As QOF registers are constructed to underpin indicators on quality of care, they do not necessarily equate to prevalence as may be defined by epidemiologists. For example, prevalence figures based on QOF registers may differ from prevalence from other sources because of coding and definitional issues.
5. The number of patients on clinical registers can be used to calculate disease prevalence, expressing the number of patients on each register as a percentage of the number of patients on practices’ lists. Therefore, ‘raw prevalence’ for a clinical area is defined as:
Raw Prevalence = (number on clinical register / number on practice list) *100
Asked by: Baroness Hayman of Ullock (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the diagnosis rate for dementia of people of each (a) age group and (b) gender in (i) Allerdale borough and (b) Copeland borough has been in each of the last 10 years.
Answered by Jane Ellison
Information is not available in the format requested.
The number of people recorded on the practice dementia disease register is available in the Quality and Outcomes Framework (QOF), published by the Health and Social Care Information Centre, from 2006/07, when dementia indicators were introduced into the framework. The diagnosis rate is not available but the numbers of people on the dementia register are available. This is a measure of prevalence rather than incidence.
Number of patients on the QOF Dementia Register in Cumbria as at 31 March
Area | Year | Number of GP practices | Number of patients on the Dementia Register | Prevalence (%) |
NHS Cumbria Clinical Commissioning Group (CCG) | 2013-14 | 82 | 4,602 | 0.88 |
NHS Cumbria CCG | 2012-13 | 82 | 4,248 | 0.81 |
Cumbria Teaching Primary Care Trust (PCT) | 2011-12 | 83 | 3,938 | 0.76 |
Cumbria PCT | 2010-11 | 90 | 3,524 | 0.68 |
Cumbria PCT | 2009-10 | 91 | 3,318 | 0.64 |
Cumbria PCT | 2008-09 | 92 | 3,114 | 0.60 |
Cumbria PCT | 2007-08 | 93 | 3,008 | 0.58 |
Cumbria PCT | 2006-07 | 95 | 2,856 | 0.56 |
Source: Health and Social Care Information Centre
Notes:
1. Data is received at practice level, however the practice data cannot be used to estimate prevalence for small areas as practices serve registered patients, not defined geographical areas. The QOF data has been provided down to CCG/PCT level.
2. The figures provided are a snapshot ‘as at 31 March each year’ and are for people of all ages, as a breakdown by age group and gender is not available.
3. The objective of the QOF is to improve the quality of care that patients are given by rewarding practices for the quality of care they provide to their patients. QOF is therefore an incentive payment scheme. Participation by practices is entirely voluntary, though participation rates are over 95%.
4. As QOF registers are constructed to underpin indicators on quality of care, they do not necessarily equate to prevalence as may be defined by epidemiologists. For example, prevalence figures based on QOF registers may differ from prevalence from other sources because of coding and definitional issues.
5. The number of patients on clinical registers can be used to calculate disease prevalence, expressing the number of patients on each register as a percentage of the number of patients on practices’ lists. Therefore, ‘raw prevalence’ for a clinical area is defined as:
Raw Prevalence = (number on clinical register / number on practice list) *100